Discover Groundbreaking Research Presented at ASH 2024
Reused with permission from the American Society of Hematology.
© 2024 The Authors. All rights reserved. Officially licensed by ASH for distribution by Kartos Therapeutics.
OUR ABSTRACTS
Explore our latest research findings presented at ASH. Below are our featured abstracts, showcasing our commitment to advancing the treatment of myelofibrosis.
Disease-Modifying Activity of Navtemadlin Correlates with Clinical Responses in a Randomized, Multicenter, Global Phase 3 Study (BOREAS) in JAK lnhibitor Relapsed/Refractory Myelofibrosis
Authors: John O. Mascarenhas, Prithviraj Bose, Hsin-An Hou, Wojciech Homenda, David Ross, Sanjay R. Mohan, Jean-Jacques Kiladjian, Haifa Kathrin Al-Ali, Andrew Charles Perkins, Yulia Khalina, Tracy Clevenger, Zhuying Huang, Jesse McGreivy, Wayne Rothbaum, Srdan Verstovsek, and Alessandro M. Vannucchi
Session Date: Sunday, December 8, 2024
Session Time: 9:30 AM – 11:00 AM
Presentation Time: 10:00 AM
Location: Manchester Grand Hyatt San Diego, Grand Hall C
Oral Presentation
Available for download beginning
11:00 AM PT on December 8, 2024
Results from the Randomized, Multicenter, Global Phase 3 BOREAS Study: Navtemadlin Versus Best Available Therapy in JAK Inhibitor Relapsed/Refractory Myelofibrosis
Authors: John O. Mascarenhas, Viola Maria Popov, Sanjay R. Mohan, Zübeyde Nur Özkurt, Jean-Jacques Kiladjian, Haifa Kathrin Al-Ali, Andrew Charles Perkins, Zhuying Huang, Hope Qamoos, Jesse McGreivy, Wayne Rothbaum, Srdan Verstovsek, and Maciej Kaźmierczak
Session Date: Monday, December 9, 2024
Session Time: 4:30 PM – 6:00 PM
Presentation Time: 5:15 PM
Location: Manchester Grand Hyatt San Diego, Harbor Ballroom DEFG
Oral Presentation
Available for download beginning
6:00 PM PT on December 9, 2024
POIESIS: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global, Phase 3 Study of Navtemadlin As Add-On Therapy to Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib Treatment
Authors: Pankit Vachhani, Raajit Rampal, Terrence Bradley, Claire Harrison, Tania Jain, Andrew T. Kuykendall, Francesca Palandri, John O. Mascarenhas, Haifa Kathrin Al-Ali, Francesco Passamonti, Anna Nekhymchuk, Hilarie Foss, Wayne Rothbaum, Srdan Verstovsek, and Florian Heidel
Session Date: Saturday, December 7, 2024
Presentation Time: 5:30 PM – 7:30 PM
Location: San Diego Convention Center, Halls G-H
Poster Presentation
Available for download beginning
7:30 PM PT on December 7, 2024